These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7644096)

  • 61. [Florid vulvar condylomatosis. Comparison of therapeutic schedules].
    Bianco V; Erba P; Remotti G
    Ann Ostet Ginecol Med Perinat; 1991; 112(4):247-56. PubMed ID: 1807188
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.
    Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
    Cancer; 1987 Feb; 59(3 Suppl):638-46. PubMed ID: 10822463
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intramuscular interferon-beta treatment of cervical intraepithelial neoplasia II associated with human papillomavirus infection.
    De Aloysio D; Miliffi L; Iannicelli T; Penacchioni P; Bottiglioni F
    Acta Obstet Gynecol Scand; 1994 May; 73(5):420-4. PubMed ID: 8009976
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients.
    Brockmeyer NH; Poffhoff A; Bader A; Hochdorfer B; Schlottmann R; Rasokat H; Altmeyer P; Kreuter A
    Eur J Med Res; 2006 Jan; 11(1):27-32. PubMed ID: 16504957
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts.
    Armstrong DK; Maw RD; Dinsmore WW; Blaakaer J; Correa MA; Falk L; Ferenczy AS; Fortier M; Frazer I; Law C; Moller BM; Oyakawa N
    Genitourin Med; 1996 Apr; 72(2):103-7. PubMed ID: 8698355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection.
    Itri LM; Campion M; Dennin RA; Palleroni AV; Gutterman JU; Groopman JE; Trown PW
    Cancer; 1987 Feb; 59(3 Suppl):668-74. PubMed ID: 10822468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.
    Minasian LM; Motzer RJ; Gluck L; Mazumdar M; Vlamis V; Krown SE
    J Clin Oncol; 1993 Jul; 11(7):1368-75. PubMed ID: 8315435
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
    Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
    Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
    Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is interferon with or without vinblastine the "treatment of choice" in metastatic renal cell carcinoma? The Norwegian Radium Hospital's experience 1983-1986.
    Fosså SD
    Semin Surg Oncol; 1988; 4(3):178-83. PubMed ID: 3055161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon alpha 2b treatment of cervical intraepithelial neoplasia grade 2: modulation of natural killer cell.
    Garzetti GG; Ciavattini A; Romanini C; Goteri G; Tranquilli AL; Muzzioli M; Fabris N
    Gynecol Obstet Invest; 1994; 37(3):204-9. PubMed ID: 8005554
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interferon alpha-2b injections used as an adjuvant therapy to carbon dioxide laser vaporization of recalcitrant ano-genital condylomata acuminata.
    Vance JC; Davis D
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):146S-148S. PubMed ID: 2124244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Atypical picture of cervico-vaginal condylomatosis in a patient submitted to hepatic transplant. A case report.
    Gentile G; Formelli G; Selva S
    Clin Exp Obstet Gynecol; 1990; 17(3-4):155-7. PubMed ID: 1963386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata.
    Trizna Z; Evans T; Bruce S; Hatch K; Tyring SK
    Sex Transm Dis; 1998 Aug; 25(7):361-5. PubMed ID: 9713916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum.
    Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Corey L; Barnum G; Pappas PG; Halloway M; Stoler MH; Reichman RC
    Antiviral Res; 1997 Jun; 35(1):41-52. PubMed ID: 9224960
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Large keratoacanthomas treated with intralesional interferon alfa-2a.
    Grob JJ; Suzini F; Richard MA; Weiller M; Zarour H; Noe C; Munoz MH; Bonerandi JJ
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):237-41. PubMed ID: 8335744
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.
    Bajetta E; Zilembo N; Di Bartolomeo M; Di Leo A; Pilotti S; Bochicchio AM; Castellani R; Buzzoni R; Celio L; Dogliotti L
    Cancer; 1993 Nov; 72(10):3099-105. PubMed ID: 7693327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.